Mamdani Wins Rent Freeze for NYC Stabilized Units Citywide
New York City's Rent Guidelines Board approved a rent freeze for one-year renewals and, for the first time, two-year ...
Which Passive Funds Beat The Market 2024 Retirement
Check which passive funds beat the market in 2024 retirement planning and what factors contributed to their outperformance.
28,482 articlesDividend Safety Check: VGIT Outlook for 2026 Investors
VGIT remains a stable Treasury income option as yields swing with policy signals. This report analyzes how duration r...
Bernstein Maintains Terawulf Target After Anthropic Lease
Major research firm reaffirmed its price target on Terawulf as the company inks a long-term lease with Anthropic and ...
Iran Just Struck Countries Sparks Crypto Markets Volatility
A geopolitical shock pushes cryptocurrency markets into volatility, with Cardano ADA tumbling toward $0.16 as Kraken ...
Mark Zuckerberg's Meta Talks on a $10B Anthropic Cloud Push
Investors are watching Meta’s next moves as chatter around a cloud-scale partnership heats up. This piece explains wh...
Bitcoin’s Divergence From Nasdaq Signals Liquidity Risk
Bitcoin is moving independently of the Nasdaq as liquidity conditions tighten, a rare divergence that traders say cou...
Reddit Split Over PayPal at $42: Steal or Trap Right Now
PayPal sits near $42 after a tough year, sparking a lively debate on whether the stock is a bargain or a trap as Q4 r...
Best Stock Scanners Screeners for March 2026 Markets Now
As markets navigate a choppy start to March 2026, traders rely on the best stock scanners screeners to turn vast data...
Should Investors Avoid Rigetti: Quantum Stock Dilemma
Rigetti Computing lives at the edge of technology and finance. This article breaks down the revenue puzzle, the risks...
Nvidia Takes Another Helping of Nebius Stock, What It Means
Nvidia has reportedly extended a new funding round for Nebius, expanding its footprint in AI infrastructure. Analysts...
Lucid Down More Than 50%? Why It Could Turn Around
Lucid has fallen sharply, dropping more than half in the last year. This article breaks down why the stock’s slump ha...
Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status